A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease has been linked to a one-third higher risk of cardiovascular-related ...

Although there is significant improvement in managing asthma and chronic obstructive pulmonary disease (COPD) diseases, there is still a strong need in controlling symptoms to prevent hospitalizations ...

Little evidence exists to support the widespread use of bronchodilators to treat children and adults with cystic fibrosis, according to a new systematic review of published research. Little evidence ...

A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

Patients with COPD also have a high prevalence of CVD. Bronchodilators prescribed for symptomatic COPD control may also contribute to cardiovascular risk. In accordance with treatment guidelines, most ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has ...

Dr. Stephen Wasserman answers the question: 'What Is A Rescue Medicine?' &#151; -- Question: What is a rescue medicine and when is it used for asthma? Answer: A rescue medicine is a medicine used in ...

- Approval of Utibron Neohaler brings an important new dual combination bronchodilator option to patients with chronic obstructive pulmonary disease (COPD). - COPD, a chronic lung disease that makes ...

A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of ...

CHICAGO --- A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of ...